MimiVax Revenue

Biotechnology Research • Buffalo, New York, United States • 1-10 Employees

MimiVax revenue & valuation

Annual revenue	$5,400,000
Revenue per employee	$1,800,000
Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues	$17,300,000
Total funding	No funding

Key Contact at MimiVax

Danielle Casucci

Vice President of Clinical Operations

Company overview

Headquarters	Buffalo, New York, United States
Phone number	+17168458850
Website	mimivax.com
NAICS	541714
SIC	283
Keywords	Oncology, Immunotherapy, Vaccines, Pharmaceutical Developement
Founded	2012
Employees	1-10
Socials

MimiVax Email Formats

MimiVax uses 1 email format. The most common is {first initial}{last name} (e.g., jdoe@mimivax.com), used 100% of the time.

Format	Example	Percentage
{first initial}{last name}	jdoe@mimivax.com	100%

About MimiVax

Our vision, to disrupt cancer with the development of highly innovative immunotherapies aimed at increasing patient survival rates MimiVax is a privately held, clinical-stage biotechnology company focused on the development and commercialization of immunotherapeutic vaccines and targeted therapies for the treatment of cancer. SurVaxM, our lead immunotherapeutic vaccine, has completed a Phase 2a clinical trial in adults with newly diagnosed glioblastoma. Additional indications are being evaluated through: - Phase 1 clinical trials in multiple myeloma combination with REVLIMID® (lenalidomide) - Phase 1 in Neuro-Endocrine Tumors (NET) - Pilot Study in Pediatric High Grade Glioma, recurrent/relapsed Medulloblastoma and DIPG

Employees by Management Level

Total employees: 1-10

Seniority

Employees

Vice President

Funding Data

MimiVax has never raised funding before.

MimiVax Tech Stack

Discover the technologies and tools that power MimiVax's digital infrastructure, from frameworks to analytics platforms.

reCAPTCHA

Security

Swiper

JavaScript libraries

jQuery UI

JavaScript libraries

Hotjar

Analytics

Elementor

Page builders

jQuery Migrate

JavaScript libraries

Cloudflare

CDN

Twitter Emoji

Font scripts

jQuery

JavaScript libraries

HTTP/3

Miscellaneous

HSTS

Security

Flickity

JavaScript libraries

Frequently asked questions

MimiVax is located in Buffalo, New York, US.

You can reach MimiVax at +17168458850.

MimiVax generates an estimated annual revenue of $5,400,000. This revenue figure reflects the company's market position and business performance in its industry.

MimiVax has an estimated valuation of $17,300,000. This valuation is calculated based on industry-standard revenue multiples and reflects the company's growth potential and market positioning.

MimiVax was founded in 2012, making it 14 years old. The company has established itself as a significant player in its industry over this time.

MimiVax has approximately 1-10 employees. The company continues to grow its workforce to support its business operations and expansion.

Key Contact at MimiVax

Danielle Casucci

Vice President of Clinical Operations

4.8

40,000 users